Watchlist Price Alert

Nabriva Therapeutics (NBRV)

NASDAQ: NBRV · Real-Time Price · USD

1.42

0.01 (0.71%)

At close: Jul 31, 2023, 8:00 PM

Nabriva Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Cash & Equivalents	1.8M	12.41M	14.65M	20.04M	33.78M	47.66M	51.99M	61.14M	54.79M	41.36M	41.12M	49.66M	26.94M	86.02M	78.1M	58.67M	91.04M	102M	100.33M	75.25M	89.44M	86.77M	112.16M	20.09M	27.17M	32.78M	24.78M	27.5M	29.45M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	16K	16K	16K	16K	16K	16K	175K	175K	175K	175K	15.25M	225K	225K	326K	225K	110K	110K	531K	33.08M	41.06M	51.11M	49.14M	59.09M	72.08M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	379K	378K	377K	378K	379K	380K	380K	380K	383K	370K	369K	368K	378K	378K	716K	710K	438K	428K	428K	428K	428K	425K	420K	408K	424K	420K	438K	436K	444K
Receivables	10.51M	6.74M	12.39M	12.36M	11.01M	12.75M	15.03M	11.58M	4.21M	3.91M	3.38M	3.23M	3.47M	2.74M	6.54M	4.77M	8.24M	5.37M	8.86M	8.32M	7.94M	5.4M	3.67M	8.7M	7.45M	5.56M	9.22M	7.84M	6.44M
Inventory	9.03M	9.68M	17.33M	15.54M	15.63M	14.51M	15.58M	10.11M	8.97M	5.82M	5.8M	5.2M	4.22M	682K	162K	n/a	-1M	-1.5M	-1.5M	-1.5M	-1.5M	n/a	n/a	n/a	n/a	-5.56M	n/a	n/a	n/a
Other Current Assets	2.36M	2.27M	3.19M	6.36M	4.78M	5.33M	5.79M	11.78M	10.46M	6.11M	3.98M	4.15M	3.37M	1.55M	1.43M	1.4M	1.97M	2.65M	2.66M	2.65M	2.52M	1.56M	1.51M	1.35M	903K	6.74M	n/a	n/a	n/a
Total Current Assets	23.69M	31.1M	47.56M	54.3M	65.2M	80.27M	88.41M	94.62M	78.44M	57.22M	54.31M	62.41M	38.17M	91.17M	86.41M	80.09M	100.48M	108.75M	110.68M	84.95M	98.5M	93.84M	117.87M	63.23M	76.58M	90.62M	83.15M	94.44M	107.98M
Property-Plant & Equipment	263K	280K	293K	206K	181K	233K	289K	355K	521K	768K	2.01M	2.18M	2.34M	2.47M	2.65M	2.76M	2.97M	1.14M	1.23M	1.28M	1.38M	1.33M	1.41M	1.44M	490K	519K	517K	910K	412K
Goodwill & Intangibles	2K	3K	7K	13K	21K	31K	41K	54K	65K	80K	84K	97K	111K	91K	343K	86K	99K	98K	109K	127K	155K	172K	199K	211K	224K	270K	191K	94K	28K
Total Long-Term Assets	644K	661K	677K	597K	581K	644K	710K	789K	969K	1.22M	2.46M	2.64M	2.83M	2.94M	3.71M	3.56M	3.51M	1.67M	1.76M	1.84M	1.96M	1.92M	2.02M	4.15M	2.37M	2.62M	2.19M	2.09M	1.52M
Total Assets	24.34M	31.77M	48.24M	54.89M	65.78M	80.91M	89.12M	95.41M	79.41M	58.44M	56.77M	65.05M	41M	94.11M	90.12M	83.64M	103.99M	110.42M	112.44M	86.79M	100.46M	95.76M	119.9M	67.37M	78.95M	93.24M	85.34M	96.52M	109.49M
Account Payables	6.98M	5.43M	3.9M	1.07M	1.58M	4.37M	1.48M	1.58M	3.64M	2.89M	2.04M	2.62M	2.03M	4.67M	3.22M	2.91M	7.56M	3.3M	4.76M	2.93M	3.81M	5.14M	5.32M	8.32M	4.34M	2.55M	2.7M	1.83M	5.16M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	374K	375K	563K	750K	750K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9K	n/a	n/a
Short-Term Debt	197K	4.83M	5.73M	6.62M	4.2M	3.77M	2.78M	1.82M	2.62M	2.04M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	10.64M	n/a	n/a
Other Current Liabilities	20.82M	17.34M	12.01M	11.63M	10.5M	13.83M	15.09M	15.24M	11.29M	12.84M	8.93M	8.38M	9.93M	11.97M	11.66M	11.2M	10.53M	14.5M	10.3M	8.36M	7.58M	8.12M	11.01M	8.43M	11.55M	13.33M	812K	10.17M	8.85M
Total Current Liabilities	28M	27.61M	21.64M	19.33M	16.27M	22.34M	19.73M	19.21M	18.3M	18.52M	10.97M	11M	11.96M	16.64M	14.88M	14.12M	18.09M	17.81M	15.06M	11.29M	11.38M	13.26M	16.33M	16.75M	15.89M	15.88M	14.16M	12M	14.01M
Long-Term Debt	345K	388K	399K	512K	3.92M	4.26M	5.17M	6.05M	5.18M	5.69M	7.61M	7.48M	7.37M	34.5M	34.24M	24.31M	23.95M	23.72M	710K	592K	411K	232K	227K	218K	203K	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	352K	479K	578K	444K	968K	954K	938K	951K	941K	1.09M	1.96M	2.12M	1.75M	1.7M	1.78M	1.82M	1.84M	264K	244K	236K	225K	203K	198K	146K	134K	107K	97K	93K	91K
Total Long-Term Liabilities	697K	867K	977K	956K	4.88M	5.22M	6.11M	7M	6.12M	6.78M	9.57M	9.59M	9.13M	36.2M	36.02M	26.12M	25.79M	23.98M	954K	828K	636K	435K	425K	364K	337K	107K	97K	93K	91K
Total Liabilities	28.7M	28.47M	22.62M	20.29M	21.16M	27.56M	25.83M	26.21M	24.42M	25.3M	20.54M	20.59M	21.09M	52.84M	50.91M	40.24M	43.88M	41.79M	16.02M	12.12M	12.02M	13.7M	16.76M	17.12M	16.23M	15.98M	14.26M	12.1M	14.1M
Total Debt	542K	5.22M	6.13M	7.14M	8.11M	8.03M	7.95M	7.87M	7.8M	7.73M	7.61M	7.48M	7.37M	34.5M	34.24M	24.31M	23.95M	23.72M	710K	592K	411K	232K	227K	218K	203K	n/a	n/a	n/a	n/a
Common Stock	32K	32K	30K	646K	617K	567K	543K	497K	354K	211K	1.5M	1.43M	951K	945K	780K	729K	713K	670K	665K	410K	402K	367K	367K	268K	2.95M	2.94M	2.32M	2.32M	2.31M
Retained Earnings	-661.56M	-652.86M	-630.08M	-618.57M	-607.5M	-595.68M	-582.61M	-571.96M	-560.21M	-546.23M	-528.39M	-515.44M	-500M	-476.74M	-453.7M	-435.9M	-414.19M	-393.98M	-363.15M	-310.33M	-292.54M	-279.2M	-256.94M	-234.67M	-220.07M	-204.84M	-176.36M	-162.39M	-150.4M
Comprehensive Income	27K	27K	27K	27K	27K	27K	27K	27K	27K	27K	27K	27K	27K	27K	27K	27K	27K	27K	27K	27K	27K	27K	27K	-16K	-7K	10K	245.12M	244.52M	243.5M
Shareholders Equity	-4.36M	3.29M	25.62M	34.6M	44.63M	53.35M	63.29M	69.2M	54.99M	33.13M	36.23M	44.46M	19.91M	41.27M	39.22M	43.41M	60.11M	68.63M	96.43M	74.67M	88.44M	82.07M	103.14M	49.55M	62.72M	77.26M	71.08M	84.43M	95.39M
Total Investments	n/a	n/a	n/a	n/a	n/a	16K	16K	16K	16K	16K	16K	175K	175K	175K	175K	15.25M	225K	225K	326K	225K	110K	110K	531K	33.08M	41.06M	51.11M	49.14M	59.09M	72.08M